REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

Q: What does CUSIP 76152G100 represent in this 13F holders report?

CUSIP 76152G100 is the security identifier for RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in Q2 2021?

11 institutional investors reported RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 76152G100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 12,863,707
Total 13F shares: 2,652,392
Share change: +2,066,064
Total reported value: $12,779,000
Price per share: $4.86
Number of holders: 11
Value change: +$9,606,649
Number of buys: 9
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 76152G100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SABBY MANAGEMENT, LLC	13F	Company	3.3%	418,437	$2,402,000	—	31 Mar 2021	13F
EMC Capital Management	13F	Company	0.59%	75,835	$435,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.28%	36,652	$210,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.27%	35,310	$203,000	—	31 Mar 2021	13F
DAVENPORT & Co LLC	13F	Company	0.12%	15,000	$86,000	—	31 Mar 2021	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.02%	3,078	$17,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	2,016	$12,000	—	31 Mar 2021	13F

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2021

As of 30 Jun 2021, REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,652,392 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, EMC Capital Management, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and DAVENPORT & Co LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.